Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis

被引:11
作者
Fainardi, Enrico [1 ]
Bortolotti, Daria [4 ]
Bolzani, Silvia [4 ]
Castellazzi, Massimiliano [3 ]
Tamborino, Carmine [3 ]
Roversi, Gloria [3 ]
Baldi, Eleonora [2 ]
Caniatti, Maria Luisa [2 ]
Casetta, Ilaria [3 ]
Gentili, Valentina [4 ]
Granieri, Enrico [3 ]
Rizzo, Roberta [4 ]
机构
[1] Azienda Osped Univ Arcispedale S Anna, Dept Neurosci & Rehabil, Neuroradil Unit, Via Aldo Moro 8, I-44124 Ferrara, Italy
[2] Azienda Osped Univ Arcispedale S Anna, Dept Neurosci & Rehabil, Neurol Unit, Via Aldo Moro 8, I-44124 Ferrara, Italy
[3] Univ Ferrara, Dept Biomed & Specialist Surg Sci, Neurol Sect, I-44100 Ferrara, Italy
[4] Univ Ferrara, Dept Med Sci, Sect Microbiol & Med Genet, I-44100 Ferrara, Italy
关键词
Multiple Sclerosis; HLA-G; dimeric form; CSF levels; MRI activity; G MOLECULES; CSF; CELLS;
D O I
10.1177/1352458515590647
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The relevance of human leukocyte antigen (HLA)-G in dimeric form in multiple sclerosis (MS) is still unknown. Objective: To investigate the contribution of cerebrospinal fluid (CSF) HLA-G dimers in MS pathogenesis. Methods: CSF amounts of 78-kDa HLA-G dimers were measured by western blot analysis in 80 MS relapsing-remitting MS (RRMS) patients and in 81 inflammatory and 70 non-inflammatory controls. Results: CSF amounts of 78kDa HLA-G dimers were more frequent in RRMS than in inflammatory (p<0.01) and non-inflammatory controls (p<0.001) and in magnetic resonance imaging (MRI) inactive than in MRI active RRMS (p<0.00001). Conclusion: Our findings suggest that HLA-G dimers may be implicated in termination of inflammatory response occurring in MS.
引用
收藏
页码:245 / 249
页数:5
相关论文
共 11 条
[1]   A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1 [J].
Apps, Richard ;
Gardner, Lucy ;
Sharkey, Andrew M. ;
Holmes, Nick ;
Moffett, Ashley .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (07) :1924-1937
[2]   CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis [J].
Fainardi, E. ;
Rizzo, R. ;
Melchiorri, L. ;
Stignani, M. ;
Costellozzi, M. ;
Tomborino, C. ;
Paolino, E. ;
Tola, M. R. ;
Granieri, E. ;
Baricordi, O. R. .
MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (04) :446-454
[3]   Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis [J].
Fainardi, E ;
Rizzo, R ;
Melchiorri, L ;
Castellazzi, M ;
Paolino, E ;
Tola, MR ;
Granieri, E ;
Baricordi, OR .
MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (01) :2-12
[4]   Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings [J].
Fainardi, E ;
Rizzo, R ;
Melchiorri, L ;
Vaghi, L ;
Castellazzi, M ;
Marzola, A ;
Govoni, V ;
Paolino, E ;
Tola, MR ;
Granieri, E ;
Baricordi, OR .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 142 (1-2) :149-158
[5]   Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting Multiple Sclerosis [J].
Fainardi, Enrico ;
Rizzo, Roberta ;
Melchiorri, Loredana ;
Stignani, Marina ;
Castellazzi, Massimiliano ;
Caniatti, Maria Luisa ;
Baldi, Eleonora ;
Tola, Maria Rosaria ;
Granieri, Enrico ;
Baricordi, Avio Roberto .
JOURNAL OF NEUROIMMUNOLOGY, 2007, 192 (1-2) :219-225
[6]   Identification of Circulating Nonclassic Human Leukocyte Antigen G (HLA-G)-Like Molecules in Exudates [J].
Gonzalez, Alvaro ;
Alegre, Estibaliz ;
Arroyo, Ainhoa ;
LeMaoult, Joeel ;
Ignacio Echeveste, Jose .
CLINICAL CHEMISTRY, 2011, 57 (07) :1013-1022
[7]   Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria [J].
Polman, Chris H. ;
Reingold, Stephen C. ;
Banwell, Brenda ;
Clanet, Michel ;
Cohen, Jeffrey A. ;
Filippi, Massimo ;
Fujihara, Kazuo ;
Havrdova, Eva ;
Hutchinson, Michael ;
Kappos, Ludwig ;
Lublin, Fred D. ;
Montalban, Xavier ;
O'Connor, Paul ;
Sandberg-Wollheim, Magnhild ;
Thompson, Alan J. ;
Waubant, Emmanuelle ;
Weinshenker, Brian ;
Wolinsky, Jerry S. .
ANNALS OF NEUROLOGY, 2011, 69 (02) :292-302
[8]   Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer [J].
Shiroishi, M ;
Kuroki, K ;
Ose, T ;
Rasubala, L ;
Shiratori, I ;
Arase, H ;
Tsumoto, K ;
Kumagai, I ;
Kohda, D ;
Maenaka, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) :10439-10447
[9]   Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis [J].
Teunissen, Charlotte ;
Menge, Til ;
Altintas, Ayse ;
Alvarez-Cermeno, Jose C. ;
Bertolotto, Antonio ;
Berven, Frode S. ;
Brundin, Lou ;
Comabella, Manuel ;
Degn, Matilde ;
Deisenhammer, Florian ;
Fazekas, Franz ;
Franciotta, Diego ;
Frederiksen, Jette L. ;
Galimberti, Daniela ;
Gnanapavan, Sharmilee ;
Hegen, Harald ;
Hemmer, Bernhard ;
Hintzen, Rogier ;
Hughes, Steve ;
Iacobaeus, Ellen ;
Kroksveen, Ann C. ;
Kuhle, Jens ;
Richert, John ;
Tumani, Hayrettin ;
Villar, Luisa M. ;
Drulovic, Jelena ;
Dujmovic, Irena ;
Khalil, Michael ;
Bartos, Ales .
MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (13) :1802-1809
[10]   Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity [J].
Wiendl, H ;
Feger, U ;
Mittelbronn, M ;
Jack, C ;
Schreiner, B ;
Stadelmann, C ;
Antel, J ;
Brueck, W ;
Meyermann, R ;
Bar-Or, A ;
Kieseier, BC ;
Weller, M .
BRAIN, 2005, 128 :2689-2704